Table 3.
Characterization of cardiovascular drugs used by elderly patients according to ACE I/D genotypes (II vs ID/DD)
| Variables | II | ID/DD | P value |
|---|---|---|---|
| No. (%) | No. (%) | ||
| No. of used cardiovascular drugs | |||
| 0 | 17 (42.5) | 74 (43.0) | .743 |
| 1 | 12 (30.0) | 41 (23.8) | |
| 2 | 7 (17.5) | 39 (22.7) | |
| 3 | 4 (10.0) | 14 (8.1) | |
| 4 | 0 (0) | 4 (8.1) | |
| Thiazide diuretics | |||
| Yes | 5 (12.5) | 37 (21.5) | .198 |
| No | 35 (87.5) | 135 (78.5) | |
| Loop diuretics | |||
| Yes | 2 (5.0) | 14 (8.1) | .742 |
| No | 38 (95.0) | 158 (91.9) | |
| Potassium‐sparing diuretics | |||
| Yes | 0 (0) | 9 (5.2) | .213 |
| No | 40 (100) | 163 (94.8) | |
| ACE inhibitors | |||
| Yes | 7 (17.5) | 28 (16.2) | .840 |
| No | 33 (82.5) | 145 (83.8) | |
| β‐Blockers | |||
| Yes | 7 (17.5) | 26 (15.1) | .708 |
| No | 33 (82.5) | 146 (84.9) | |
| ATR1 blockers | |||
| Yes | 9 (22.5) | 39 (22.7) | .981 |
| No | 31 (77.5) | 133 (77.3) | |
| Calcium channel blockers | |||
| Yes | 7 (17.5) | 21 (12.4) | .397 |
| No | 33 (82.5) | 148 (87.6) | |
ACE, angiotensin‐converting enzyme; ATR1, angiotensin II type 1 receptor; D, deletion, I, insertion.
Data from Aiquara, Bahia, Brazil (2015).